SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of
1934
(Amendment No. 1)
ENANTA PHARMACEUTICALS, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
29251M106
(CUSIP Number)
December 31, 2014
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ¨ | Rule 13d-1(b) | |
| x | Rule 13d-1(c) | |
| ¨ | Rule 13d-1(d) |
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 29251M106 | 13G | Page 2 of 5 Pages |
| 1. |
Names of Reporting Persons Alan J. Dworsky | ||
| 2. |
Check the Appropriate Box if a Member of a Group (a) ¨ (See Instructions) (b) ¨
| ||
| 3. |
SEC Use Only
| ||
| 4. |
Citizenship or Place of Organization United States
| ||
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5.
|
Sole Voting Power
543,540
| |
| 6. |
Shared Voting Power
571,445
| ||
| 7. |
Sole Dispositive Power
543,540
| ||
| 8. |
Shared Dispositive Power
571,445
| ||
| 9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
1,114,985
| ||
| 10. |
Check if the Aggregate Amount in Row (9) Excludes Certain Shares ¨ (See Instructions)
| ||
| 11. |
Percent of Class Represented by Amount in Row (9)
6.0%
| ||
| 12. |
Type of Reporting Person (See Instructions)
IN
| ||
| CUSIP No. 29251M106 | 13G | Page 3 of 5 Pages |
| Item 1(a). | Name of Issuer |
Enanta Pharmaceuticals, Inc. (the “Issuer”).
| Item 1(b). | Address of Issuer’s Principal Executive Offices |
500 Arsenal Street, Watertown, MA 02472.
| Item 2(a). | Name of Person Filing |
Alan J. Dworsky
| Item 2(b). | Address of Principal Offices or, if None, Residence |
8 Mercer Circle, Cambridge, MA 02138
| Item 2(c). | Citizenship |
Mr. Dworsky is a United States citizen.
| Item 2(d). | Title of Class of Securities |
Common stock (“Common Stock”).
| Item 2(e). | CUSIP Number |
29251M106
| Item 3. | If the statement is being filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the filing person is a: |
Not Applicable
| Item 4. | Ownership |
(a) Amount beneficially owned:
Mr. Dworsky beneficially owns an aggregate of 1,114,985 shares of Common Stock comprised of (i) 571,445 shares held by the Alan J. Dworsky 1988 Trust u/d/t dated January 6, 1988, as amended, of which Mr. Dworsky is a trustee and over which shares Mr. Dworsky has shared voting and dispositive power, (ii) 386,231 shares held by the Alan J. Dworsky Grandchildren’s Trusts u/d/t dated July 14, 1995, as amended, of which Mr. Dworsky is a trustee and over which shares Mr. Dworsky has sole voting and dispositive power, and (iii) 157,309 shares held by the Popplestone Foundation u/d/t dated August 15, 2000, of which Mr. Dworsky is a trustee and has sole voting and dispositive power.
(b) Percent of class:
6.0%, based upon 18,614,944 shares of Common Stock outstanding as of January 7, 2015, as reported in the Issuer’s Definitive Proxy Statement filed with the Securities and Exchange Commission on January 15, 2015.
(c) Number of shares as to which the person has:
(i) Sole power to vote or direct the vote: 543,540
(ii) Shared power to vote or direct the vote: 571,445
| CUSIP No. 29251M106 | 13G | Page 4 of 5 Pages |
(iii) Sole power to dispose or to direct the disposition of: 543,540
(iv) Shared power to dispose or to direct the disposition of: 571,445
| Item 5. | Ownership of Five Percent or Less of a Class |
Not Applicable
| Item 6. | Ownership of More Than Five Percent on Behalf of Another Person |
Not Applicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person |
Not Applicable
| Item 8. | Identification and Classification of Members of the Group |
Not Applicable
| Item 9. | Notice of Dissolution of Group |
Not Applicable
| Item 10. | Certification |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: February 10, 2015
/s/ Alan j. Dworsky
Alan J. Dworsky
Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).